25 XP   0   0   10

Vaishali Pharma Limited
Buy, Hold or Sell?

Let's analyse Vaishali Pharma Limited together

PenkeI guess you are interested in Vaishali Pharma Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Vaishali Pharma Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Vaishali Pharma Limited

I send you an email if I find something interesting about Vaishali Pharma Limited.

Quick analysis of Vaishali Pharma Limited (30 sec.)










What can you expect buying and holding a share of Vaishali Pharma Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
INR36.28
Expected worth in 1 year
INR81.44
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
INR45.16
Return On Investment
27.9%

For what price can you sell your share?

Current Price per Share
INR162.00
Expected price per share
INR135.90 - INR174.90
How sure are you?
50%

1. Valuation of Vaishali Pharma Limited (5 min.)




Live pricePrice per Share (EOD)

INR162.00

Intrinsic Value Per Share

INR-34.21 - INR78.53

Total Value Per Share

INR2.07 - INR114.81

2. Growth of Vaishali Pharma Limited (5 min.)




Is Vaishali Pharma Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$4.8m$3.1m$1.7m35.0%

How much money is Vaishali Pharma Limited making?

Current yearPrevious yearGrowGrow %
Making money$792.4k$482.8k$309.5k39.1%
Net Profit Margin9.5%5.6%--

How much money comes from the company's main activities?

3. Financial Health of Vaishali Pharma Limited (5 min.)




What can you expect buying and holding a share of Vaishali Pharma Limited? (5 min.)

Welcome investor! Vaishali Pharma Limited's management wants to use your money to grow the business. In return you get a share of Vaishali Pharma Limited.

What can you expect buying and holding a share of Vaishali Pharma Limited?

First you should know what it really means to hold a share of Vaishali Pharma Limited. And how you can make/lose money.

Speculation

The Price per Share of Vaishali Pharma Limited is INR162.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Vaishali Pharma Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Vaishali Pharma Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR36.28. Based on the TTM, the Book Value Change Per Share is INR11.29 per quarter. Based on the YOY, the Book Value Change Per Share is INR3.73 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Vaishali Pharma Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.070.0%0.070.0%0.050.0%0.030.0%0.020.0%
Usd Book Value Change Per Share0.140.1%0.140.1%0.040.0%0.040.0%0.040.0%
Usd Dividend Per Share0.000.0%0.000.0%0.040.0%0.010.0%0.000.0%
Usd Total Gains Per Share0.140.1%0.140.1%0.080.0%0.050.0%0.040.0%
Usd Price Per Share1.75-1.75-0.79-0.79-0.47-
Price to Earnings Ratio24.69-24.69-17.34-285.51-150.84-
Price-to-Total Gains Ratio12.92-12.92-9.94--457.72--380.79-
Price to Book Ratio4.02-4.02-2.65-2.46-1.55-
Price-to-Total Gains Ratio12.92-12.92-9.94--457.72--380.79-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.944
Number of shares514
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share0.140.04
Usd Total Gains Per Share0.140.05
Gains per Quarter (514 shares)69.6324.26
Gains per Year (514 shares)278.5397.05
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10279269148387
2055754829165184
3083682743248281
401114110658330378
501393138572413475
601671166487496572
7019501943101578669
8022282222115661766
9025072501130744863
10027852780144826960

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%10.01.00.090.9%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%9.01.00.090.0%10.01.00.090.9%
Dividend per Share0.00.01.00.0%1.00.02.033.3%1.00.04.020.0%1.00.09.010.0%1.00.010.09.1%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%9.01.00.090.0%10.01.00.090.9%

Fundamentals of Vaishali Pharma Limited

About Vaishali Pharma Limited

Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers active pharmaceutical ingredients (APIs), including antibiotics, anti-ulcer, anti-inflammatory/analgesic/anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, anti-diarrheal/anti-protozoal/anti-parasitic, anti-viral, anti-epileptic, anti-asthmatic, anti-fungal, anti-platelet agent, skeletal muscle relaxant, and anti-helmintic drugs, as well as excipients, topical steroids, corticosteroids, and enzymes. The company also provides formulation products, such as laxative, anti-ulcer/enzyme, anti-asthmatic, anti-viral, anti-psychotic, vitamins, and other formulations. In addition, it offers veterinary pharmaceutical, nutraceutical, oncology, herbal, and surgical products. Vaishali Pharma Limited was founded in 1989 and is headquartered in Mumbai, India.

Fundamental data was last updated by Penke on 2024-04-09 11:55:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Vaishali Pharma Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Vaishali Pharma Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Vaishali Pharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 9.5% means that ₹0.09 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Vaishali Pharma Limited:

  • The MRQ is 9.5%. The company is making a profit. +1
  • The TTM is 9.5%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ9.5%TTM9.5%0.0%
TTM9.5%YOY5.6%+3.9%
TTM9.5%5Y3.6%+5.9%
5Y3.6%10Y2.1%+1.6%
1.1.2. Return on Assets

Shows how efficient Vaishali Pharma Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Vaishali Pharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 8.4% Return on Assets means that Vaishali Pharma Limited generated ₹0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Vaishali Pharma Limited:

  • The MRQ is 8.4%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 8.4%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ8.4%TTM8.4%0.0%
TTM8.4%YOY4.9%+3.4%
TTM8.4%5Y3.1%+5.2%
5Y3.1%10Y1.9%+1.2%
1.1.3. Return on Equity

Shows how efficient Vaishali Pharma Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Vaishali Pharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 16.3% Return on Equity means Vaishali Pharma Limited generated ₹0.16 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Vaishali Pharma Limited:

  • The MRQ is 16.3%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 16.3%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ16.3%TTM16.3%0.0%
TTM16.3%YOY15.3%+1.0%
TTM16.3%5Y7.9%+8.3%
5Y7.9%10Y7.5%+0.5%

1.2. Operating Efficiency of Vaishali Pharma Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Vaishali Pharma Limited is operating .

  • Measures how much profit Vaishali Pharma Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Vaishali Pharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 15.6% means the company generated ₹0.16  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Vaishali Pharma Limited:

  • The MRQ is 15.6%. The company is operating efficient. +1
  • The TTM is 15.6%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ15.6%TTM15.6%0.0%
TTM15.6%YOY11.5%+4.1%
TTM15.6%5Y11.0%+4.6%
5Y11.0%10Y7.9%+3.1%
1.2.2. Operating Ratio

Measures how efficient Vaishali Pharma Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.88 means that the operating costs are ₹0.88 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Vaishali Pharma Limited:

  • The MRQ is 0.876. The company is less efficient in keeping operating costs low.
  • The TTM is 0.876. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.876TTM0.8760.000
TTM0.876YOY0.910-0.034
TTM0.8765Y0.921-0.045
5Y0.92110Y0.950-0.029

1.3. Liquidity of Vaishali Pharma Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Vaishali Pharma Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.27 means the company has ₹2.27 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Vaishali Pharma Limited:

  • The MRQ is 2.266. The company is able to pay all its short-term debts. +1
  • The TTM is 2.266. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.266TTM2.2660.000
TTM2.266YOY1.472+0.794
TTM2.2665Y1.622+0.644
5Y1.62210Y1.415+0.206
1.3.2. Quick Ratio

Measures if Vaishali Pharma Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Vaishali Pharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 2.43 means the company can pay off ₹2.43 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Vaishali Pharma Limited:

  • The MRQ is 2.430. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.430. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.430TTM2.4300.000
TTM2.430YOY1.691+0.738
TTM2.4305Y1.688+0.742
5Y1.68810Y1.187+0.501

1.4. Solvency of Vaishali Pharma Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Vaishali Pharma Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Vaishali Pharma Limited to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.49 means that Vaishali Pharma Limited assets are financed with 48.6% credit (debt) and the remaining percentage (100% - 48.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Vaishali Pharma Limited:

  • The MRQ is 0.486. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.486. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.486TTM0.4860.000
TTM0.486YOY0.677-0.191
TTM0.4865Y0.654-0.167
5Y0.65410Y0.767-0.113
1.4.2. Debt to Equity Ratio

Measures if Vaishali Pharma Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Vaishali Pharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 94.7% means that company has ₹0.95 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Vaishali Pharma Limited:

  • The MRQ is 0.947. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.947. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.947TTM0.9470.000
TTM0.947YOY2.097-1.150
TTM0.9475Y2.039-1.092
5Y2.03910Y6.670-4.631

2. Market Valuation of Vaishali Pharma Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Vaishali Pharma Limited generates.

  • Above 15 is considered overpriced but always compare Vaishali Pharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 24.69 means the investor is paying ₹24.69 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Vaishali Pharma Limited:

  • The EOD is 27.411. Based on the earnings, the company is overpriced. -1
  • The MRQ is 24.687. Based on the earnings, the company is fair priced.
  • The TTM is 24.687. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD27.411MRQ24.687+2.724
MRQ24.687TTM24.6870.000
TTM24.687YOY17.339+7.348
TTM24.6875Y285.505-260.819
5Y285.50510Y150.838+134.667
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Vaishali Pharma Limited:

  • The EOD is 231.297. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 208.310. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 208.310. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD231.297MRQ208.310+22.987
MRQ208.310TTM208.3100.000
TTM208.310YOY153.743+54.567
TTM208.3105Y82.322+125.988
5Y82.32210Y40.501+41.821
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Vaishali Pharma Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 4.02 means the investor is paying ₹4.02 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Vaishali Pharma Limited:

  • The EOD is 4.465. Based on the equity, the company is fair priced.
  • The MRQ is 4.022. Based on the equity, the company is fair priced.
  • The TTM is 4.022. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD4.465MRQ4.022+0.444
MRQ4.022TTM4.0220.000
TTM4.022YOY2.647+1.375
TTM4.0225Y2.464+1.557
5Y2.46410Y1.545+0.919
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Vaishali Pharma Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--11.28911.2890%3.732+203%3.349+237%3.365+236%
Book Value Per Share--36.27936.2790%24.989+45%24.618+47%15.536+134%
Current Ratio--2.2662.2660%1.472+54%1.622+40%1.415+60%
Debt To Asset Ratio--0.4860.4860%0.677-28%0.654-26%0.767-37%
Debt To Equity Ratio--0.9470.9470%2.097-55%2.039-54%6.670-86%
Dividend Per Share----0%2.924-100%0.585-100%0.292-100%
Eps--5.9105.9100%3.815+55%2.285+159%1.326+346%
Free Cash Flow Per Share--0.7000.7000%0.430+63%1.668-58%-0.795+213%
Free Cash Flow To Equity Per Share---0.850-0.8500%0.826-203%-0.259-70%-1.024+20%
Gross Profit Margin--0.9200.9200%0.336+174%-6.166+770%-2.749+399%
Intrinsic Value_10Y_max--78.530--------
Intrinsic Value_10Y_min---34.208--------
Intrinsic Value_1Y_max--3.012--------
Intrinsic Value_1Y_min---1.473--------
Intrinsic Value_3Y_max--12.751--------
Intrinsic Value_3Y_min---6.146--------
Intrinsic Value_5Y_max--26.954--------
Intrinsic Value_5Y_min---12.667--------
Market Cap1708484400.000+5%1630025876.7001630025876.7000%697631989.950+134%710520101.320+129%419750063.660+288%
Net Profit Margin--0.0950.0950%0.056+69%0.036+161%0.021+357%
Operating Margin--0.1560.1560%0.115+36%0.110+41%0.079+97%
Operating Ratio--0.8760.8760%0.910-4%0.921-5%0.950-8%
Pb Ratio4.465+10%4.0224.0220%2.647+52%2.464+63%1.545+160%
Pe Ratio27.411+10%24.68724.6870%17.339+42%285.505-91%150.838-84%
Price Per Share162.000+10%145.900145.9000%66.150+121%65.640+122%38.935+275%
Price To Free Cash Flow Ratio231.297+10%208.310208.3100%153.743+35%82.322+153%40.501+414%
Price To Total Gains Ratio14.350+10%12.92412.9240%9.939+30%-457.716+3642%-380.788+3046%
Quick Ratio--2.4302.4300%1.691+44%1.688+44%1.187+105%
Return On Assets--0.0840.0840%0.049+70%0.031+168%0.019+336%
Return On Equity--0.1630.1630%0.153+7%0.079+105%0.075+118%
Total Gains Per Share--11.28911.2890%6.656+70%3.934+187%3.657+209%
Usd Book Value--4863744.0004863744.0000%3162501.480+54%3170023.162+53%1993400.776+144%
Usd Book Value Change Per Share--0.1350.1350%0.045+203%0.040+237%0.040+236%
Usd Book Value Per Share--0.4350.4350%0.300+45%0.295+47%0.186+134%
Usd Dividend Per Share----0%0.035-100%0.007-100%0.004-100%
Usd Eps--0.0710.0710%0.046+55%0.027+159%0.016+346%
Usd Free Cash Flow--93900.00093900.0000%54451.920+72%212146.078-56%-100023.062+207%
Usd Free Cash Flow Per Share--0.0080.0080%0.005+63%0.020-58%-0.010+213%
Usd Free Cash Flow To Equity Per Share---0.010-0.0100%0.010-203%-0.003-70%-0.012+20%
Usd Market Cap20501812.800+5%19560310.52019560310.5200%8371583.879+134%8526241.216+129%5037000.764+288%
Usd Price Per Share1.944+10%1.7511.7510%0.794+121%0.788+122%0.467+275%
Usd Profit--792420.000792420.0000%482844.000+64%298075.270+166%171753.568+361%
Usd Revenue--8359536.0008359536.0000%8584412.652-3%7784981.326+7%8854835.947-6%
Usd Total Gains Per Share--0.1350.1350%0.080+70%0.047+187%0.044+209%
 EOD+4 -4MRQTTM+0 -0YOY+27 -95Y+26 -1010Y+30 -6

3.2. Fundamental Score

Let's check the fundamental score of Vaishali Pharma Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1527.411
Price to Book Ratio (EOD)Between0-14.465
Net Profit Margin (MRQ)Greater than00.095
Operating Margin (MRQ)Greater than00.156
Quick Ratio (MRQ)Greater than12.430
Current Ratio (MRQ)Greater than12.266
Debt to Asset Ratio (MRQ)Less than10.486
Debt to Equity Ratio (MRQ)Less than10.947
Return on Equity (MRQ)Greater than0.150.163
Return on Assets (MRQ)Greater than0.050.084
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of Vaishali Pharma Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.732
Ma 20Greater thanMa 50153.903
Ma 50Greater thanMa 100152.583
Ma 100Greater thanMa 200163.569
OpenGreater thanClose156.000
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets789,074
Total Liabilities383,762
Total Stockholder Equity405,312
 As reported
Total Liabilities 383,762
Total Stockholder Equity+ 405,312
Total Assets = 789,074

Assets

Total Assets789,074
Total Current Assets726,807
Long-term Assets62,267
Total Current Assets
Cash And Cash Equivalents 5,291
Short-term Investments 118,945
Net Receivables 536,205
Inventory 30,501
Other Current Assets 35,865
Total Current Assets  (as reported)726,807
Total Current Assets  (calculated)726,807
+/-0
Long-term Assets
Property Plant Equipment 17,979
Intangible Assets 8,561
Long-term Assets Other 17,917
Long-term Assets  (as reported)62,267
Long-term Assets  (calculated)44,457
+/- 17,810

Liabilities & Shareholders' Equity

Total Current Liabilities320,780
Long-term Liabilities62,982
Total Stockholder Equity405,312
Total Current Liabilities
Short-term Debt 86,272
Short Long Term Debt 84,366
Accounts payable 180,076
Other Current Liabilities 31,341
Total Current Liabilities  (as reported)320,780
Total Current Liabilities  (calculated)382,055
+/- 61,275
Long-term Liabilities
Long term Debt Total 61,090
Other Liabilities 1,893
Long-term Liabilities  (as reported)62,982
Long-term Liabilities  (calculated)62,983
+/- 1
Total Stockholder Equity
Common Stock105,462
Retained Earnings 141,923
Accumulated Other Comprehensive Income 77,208
Total Stockholder Equity (as reported)405,312
Total Stockholder Equity (calculated)324,593
+/- 80,719
Other
Capital Stock105,462
Cash And Equivalents9,847
Cash and Short Term Investments 124,236
Common Stock Shares Outstanding 11,172
Current Deferred Revenue23,091
Liabilities and Stockholders Equity 789,074
Net Debt 142,071
Net Invested Capital 541,946
Net Tangible Assets 396,758
Net Working Capital 406,027
Property Plant and Equipment Gross 17,979
Short Long Term Debt Total 147,362



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-31
> Total Assets 
485,817
534,297
457,950
497,725
446,487
643,233
687,511
662,039
861,233
816,240
789,074
789,074816,240861,233662,039687,511643,233446,487497,725457,950534,297485,817
   > Total Current Assets 
475,902
517,549
436,855
448,339
427,225
590,507
629,702
613,065
812,931
764,252
726,807
726,807764,252812,931613,065629,702590,507427,225448,339436,855517,549475,902
       Cash And Cash Equivalents 
18,036
10,119
10,074
2,308
10,658
2,081
2,300
2,832
3,135
11,623
5,291
5,29111,6233,1352,8322,3002,08110,6582,30810,07410,11918,036
       Short-term Investments 
0
0
0
0
4,437
95,855
-32,165
-21,265
119,653
120,534
118,945
118,945120,534119,653-21,265-32,16595,8554,4370000
       Net Receivables 
0
0
0
404,164
379,005
451,138
617,589
583,891
786,960
746,340
536,205
536,205746,340786,960583,891617,589451,138379,005404,164000
       Inventory 
53,431
81,469
33,193
33,600
11,547
18,680
9,813
8,801
5,882
6,290
30,501
30,5016,2905,8828,8019,81318,68011,54733,60033,19381,46953,431
       Other Current Assets 
404,435
425,961
393,588
412,431
405,020
569,746
0
601,432
16,954
0
35,865
35,865016,954601,4320569,746405,020412,431393,588425,961404,435
   > Long-term Assets 
9,915
16,748
21,095
49,386
19,262
52,725
57,809
48,974
48,302
51,987
62,267
62,26751,98748,30248,97457,80952,72519,26249,38621,09516,7489,915
       Property Plant Equipment 
1,772
6,036
16,771
13,719
11,366
9,847
8,784
11,683
9,706
9,035
17,979
17,9799,0359,70611,6838,7849,84711,36613,71916,7716,0361,772
       Intangible Assets 
0
48
18
1,912
131
3,610
4,948
3,968
2,935
7,692
8,561
8,5617,6922,9353,9684,9483,6101311,91218480
       Long-term Assets Other 
8,114
10,664
4,306
32,536
7,551
38,062
0
21,265
23,365
22,838
17,917
17,91722,83823,36521,265038,0627,55132,5364,30610,6648,114
> Total Liabilities 
458,087
503,561
425,600
465,188
407,802
437,217
473,521
448,225
637,048
552,698
383,762
383,762552,698637,048448,225473,521437,217407,802465,188425,600503,561458,087
   > Total Current Liabilities 
429,288
471,668
342,020
449,040
347,884
408,936
424,783
404,156
592,605
519,369
320,780
320,780519,369592,605404,156424,783408,936347,884449,040342,020471,668429,288
       Short-term Debt 
68,144
157,661
158,273
195,552
153,767
157,498
122,967
127,761
135,904
176,676
86,272
86,272176,676135,904127,761122,967157,498153,767195,552158,273157,66168,144
       Short Long Term Debt 
0
0
0
0
153,767
157,498
122,967
125,844
116,238
176,559
84,366
84,366176,559116,238125,844122,967157,498153,7670000
       Accounts payable 
359,106
310,972
171,746
240,445
161,185
223,833
245,278
217,332
405,366
283,807
180,076
180,076283,807405,366217,332245,278223,833161,185240,445171,746310,972359,106
       Other Current Liabilities 
2,038
3,035
12,001
12,601
32,932
22,855
49,250
14,502
22,354
15,157
31,341
31,34115,15722,35414,50249,25022,85532,93212,60112,0013,0352,038
   > Long-term Liabilities 
28,799
31,893
83,580
16,148
59,918
28,281
48,739
44,069
44,443
33,329
62,982
62,98233,32944,44344,06948,73928,28159,91816,14883,58031,89328,799
       Long term Debt Total 
0
0
0
44,781
33,727
26,455
47,797
42,681
42,593
31,438
61,090
61,09031,43842,59342,68147,79726,45533,72744,781000
       Other Liabilities 
0
0
0
0
1,982
1,826
942
1,388
1,850
1,892
1,893
1,8931,8921,8501,3889421,8261,9820000
> Total Stockholder Equity
27,730
30,736
32,350
32,537
38,685
206,016
213,990
213,814
224,186
263,542
405,312
405,312263,542224,186213,814213,990206,01638,68532,53732,35030,73627,730
   Common Stock
5,000
5,000
5,000
5,000
30,000
65,914
65,914
105,462
105,462
105,462
105,462
105,462105,462105,462105,46265,91465,91430,0005,0005,0005,0005,000
   Retained Earnings Total Equity00000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
1,142
1,051
1,215
77,208
77,2081,2151,0511,1420000000
   Capital Surplus 00000000000
   Treasury Stock00000000000
   Other Stockholders Equity 
22,730
25,736
27,350
0
8,685
122,376
123,214
-130,651
82,021
80,976
-247,385
-247,38580,97682,021-130,651123,214122,3768,685027,35025,73622,730



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue696,628
Cost of Revenue-546,776
Gross Profit149,852149,852
 
Operating Income (+$)
Gross Profit149,852
Operating Expense-63,601
Operating Income88,73886,251
 
Operating Expense (+$)
Research Development0
Selling General Administrative3,775
Selling And Marketing Expenses5,292
Operating Expense63,6019,067
 
Net Interest Income (+$)
Interest Income20,085
Interest Expense-20,085
Other Finance Cost-20,085
Net Interest Income-20,085
 
Pretax Income (+$)
Operating Income88,738
Net Interest Income-20,085
Other Non-Operating Income Expenses0
Income Before Tax (EBT)88,45389,014
EBIT - interestExpense = 88,453
88,459
86,120
Interest Expense20,085
Earnings Before Interest and Taxes (EBIT)108,538108,538
Earnings Before Interest and Taxes (EBITDA)113,582
 
After tax Income (+$)
Income Before Tax88,453
Tax Provision-22,424
Net Income From Continuing Ops66,02966,029
Net Income66,035
Net Income Applicable To Common Shares66,029
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses610,377
Total Other Income/Expenses Net-27620,085
 

Technical Analysis of Vaishali Pharma Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Vaishali Pharma Limited. The general trend of Vaishali Pharma Limited is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Vaishali Pharma Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Vaishali Pharma Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 174.15 < 174.45 < 174.90.

The bearish price targets are: 150.05 > 136.05 > 135.90.

Tweet this
Vaishali Pharma Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Vaishali Pharma Limited. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Vaishali Pharma Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Vaishali Pharma Limited. The current macd is 2.68239318.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Vaishali Pharma Limited price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Vaishali Pharma Limited. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Vaishali Pharma Limited price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Vaishali Pharma Limited Daily Moving Average Convergence/Divergence (MACD) ChartVaishali Pharma Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Vaishali Pharma Limited. The current adx is 24.19.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Vaishali Pharma Limited shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Vaishali Pharma Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Vaishali Pharma Limited. The current sar is 150.31.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Vaishali Pharma Limited Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Vaishali Pharma Limited. The current rsi is 55.73. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Vaishali Pharma Limited Daily Relative Strength Index (RSI) ChartVaishali Pharma Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Vaishali Pharma Limited. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Vaishali Pharma Limited price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Vaishali Pharma Limited Daily Stochastic Oscillator ChartVaishali Pharma Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Vaishali Pharma Limited. The current cci is 52.03.

Vaishali Pharma Limited Daily Commodity Channel Index (CCI) ChartVaishali Pharma Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Vaishali Pharma Limited. The current cmo is 14.27.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Vaishali Pharma Limited Daily Chande Momentum Oscillator (CMO) ChartVaishali Pharma Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Vaishali Pharma Limited. The current willr is -41.74757282.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Vaishali Pharma Limited is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Vaishali Pharma Limited Daily Williams %R ChartVaishali Pharma Limited Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Vaishali Pharma Limited.

Vaishali Pharma Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Vaishali Pharma Limited. The current atr is 9.60987121.

Vaishali Pharma Limited Daily Average True Range (ATR) ChartVaishali Pharma Limited Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Vaishali Pharma Limited. The current obv is 20,199,145.

Vaishali Pharma Limited Daily On-Balance Volume (OBV) ChartVaishali Pharma Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Vaishali Pharma Limited. The current mfi is 82.87.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Vaishali Pharma Limited Daily Money Flow Index (MFI) ChartVaishali Pharma Limited Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Vaishali Pharma Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-07ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-17RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Vaishali Pharma Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Vaishali Pharma Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.732
Ma 20Greater thanMa 50153.903
Ma 50Greater thanMa 100152.583
Ma 100Greater thanMa 200163.569
OpenGreater thanClose156.000
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Vaishali Pharma Limited with someone you think should read this too:
  • Are you bullish or bearish on Vaishali Pharma Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Vaishali Pharma Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Vaishali Pharma Limited

I send you an email if I find something interesting about Vaishali Pharma Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Vaishali Pharma Limited.

Receive notifications about Vaishali Pharma Limited in your mailbox!